ICON plc to Present at UBS Virtual Global Healthcare Conference
May 13 2020 - 6:00AM
Business Wire
ICON plc, (NASDAQ: ICLR) a global provider of drug and device
development and commercialisation services to the pharmaceutical,
biotechnology and medical device industries, today announced that
Mr. Brendan Brennan, CFO of ICON plc, will present at the UBS
Virtual Global Healthcare Conference on Wednesday, May 20, 2020.
The presentation will be webcast live from 09.10am EDT.
A link to the live webcast will be available via the Investor
section of our website under “Events”.
About ICON plc
ICON plc is a global provider of outsourced drug and device
development and commercialisation services to pharmaceutical,
biotechnology, medical device and government and public health
organisations. The Company specialises in the strategic
development, management and analysis of programs that support
clinical development - from compound selection to Phase I-IV
clinical studies. With headquarters in Dublin, Ireland, ICON
employed approximately 15,100 employees in 98 locations in 40
countries as at March 31, 2020. Further information is available at
www.iconplc.com.
This press release contains forward-looking statements. These
statements are based on management's current expectations and
information currently available, including current economic and
industry conditions. These statements are not guarantees of future
performance or actual results, and actual results, developments and
business decisions may differ from those stated in this press
release. The forward-looking statements are subject to future
events, risks, uncertainties and other factors that could cause
actual results to differ materially from those projected in the
statements, including, but not limited to, the ability to enter
into new contracts, maintain client relationships, manage the
opening of new offices and offering of new services, the
integration of new business mergers and acquisitions, the impact of
COVID-19 on our business, as well as other economic and global
market conditions and other risks and uncertainties detailed from
time to time in SEC reports filed by ICON, all of which are
difficult to predict and some of which are beyond our control. For
these reasons, you should not place undue reliance on these
forward-looking statements when making investment decisions. The
word "expected" and variations of such words and similar
expressions are intended to identify forward-looking statements.
Forward-looking statements are only as of the date they are made
and we do not undertake any obligation to update publicly any
forward-looking statement, either as a result of new information,
future events or otherwise. More information about the risks and
uncertainties relating to these forward-looking statements may be
found in SEC reports filed by ICON, including its Form 20-F, F-1,
S-8 and F-3, which are available on the SEC's website at
http://www.sec.gov.
Source: ICON plc
ICON/ICLR-G
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200513005275/en/
Investor Relations +1888 381 7923 or Jonathan Curtain Vice
President Corporate Finance and Investor Relations +353 1 291
2000
ICON (NASDAQ:ICLR)
Historical Stock Chart
From Mar 2024 to Apr 2024
ICON (NASDAQ:ICLR)
Historical Stock Chart
From Apr 2023 to Apr 2024